Arena Pharmaceuticals (ARNA) Tops Q3 EPS by 7c, Updates Guidance
Tweet Send to a Friend
Arena Pharmaceuticals (Nasdaq: ARNA) reports a Q3 loss of $0.76, 7 cents better than the analyst estimate of ($0.83). Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
